FDA advisory panel votes overwhelmingly against MDMA therapy for PTSD
FDA advisory panel votes overwhelmingly against MDMA therapy for PTSD
www.statnews.com FDA advisory panel votes overwhelmingly against MDMA therapy for PTSD
An FDA advisory committee is meeting today to review MDMA-assisted psychotherapy to treat PTSD. Follow STAT's live blog throughout the day for updates.
You're viewing a single thread.
8
comments
8
comments